Invention Grant
- Patent Title: Mitochondrial-derived peptide MOTS3 regulates metabolism and cell survival
-
Application No.: US15146249Application Date: 2016-05-04
-
Publication No.: US10064914B2Publication Date: 2018-09-04
- Inventor: Pinchas Cohen , Changhan Lee
- Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Applicant Address: US CA Oakland
- Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee Address: US CA Oakland
- Agency: Morgan, Lewis & Bockius LLP
- Agent Jeffry S. Mann; Louis T. Nguyen
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61K9/00 ; C07K16/18 ; C07K14/47
Abstract:
MOTS3 is a novel polypeptide. Methods of treating diseases such as diabetes, obesity, fatty liver, and cancer using MOTS3 and pharmaceutical compositions thereof are disclosed herein.
Public/Granted literature
- US20170049853A1 MITOCHONDRIAL-DERIVED PEPTIDE MOTS3 REGULATES METABOLISM AND CELL SURVIVAL Public/Granted day:2017-02-23
Information query
IPC分类:
